- Home
- Products
- Distributors
- Education
- News & Events
- About Us
- Contact Us
You are seeing this text because you don't have an appropriate Flash Player to view it. You need Flash Player 8 or later to view the Flash items of this site. If you are sure you have Flash 8 or later and you have JavaScript enabled you can click here to bypass the detection.
February 24th, 2010
Meridian Medical Inc is proud to announce that the American Society of Lasers in Medicine & Surgery (ASLMS) (www.aslms.org) has accepted the Lapex BCS Low Level Laser Therapy research abstract for presentation at the 30th Annual Conference to be held in April 14-18, 2010 in Phoenix, Arizona.
Approximately 900 abstracts are submitted each year to the ASLMS and less than 10% are accepted for presentation based on the quality and significance of research. ASLMS is the premier forum for state-of-the-art education and unmatched value of the biggest event for innovation in medical lasers and related products. The abstract will be permanently hosted on the ASLMS archives after the annual meeting and will serve as a great educational tool for physicians.
"This is further proof that the Lapex BCS LipoLaser works as therapy, helping patients in their quest to reduce subcutaneous fat and body contouring" said Dr. Vinod Podichetty Chief Scientific Advisor for Meridian Medical Inc., North American Distributor for Meridian Co. "The purpose of the study was to assess clinical effects of the Lapex BCS low level laser therapy on subcutaneous fat reduction and improvement in body contouring, the objectives have been met in this research study" Podichetty goes on to say.
Currently, the Lapex BCS LipoLaser is a U.S. Food and Drug Administration (FDA) approved technology for pain alleviation. "We are proud to contribute such impactful data on body ...